BiondVax teams up with Max Planck Society on developing VHH antibodies against COVID-19
BiondVax signed an agreement for a broad-based strategic collaboration with the Max Planck Society (MPG) and University Medical Center Göttingen (UMG), Germany. This 5-year strategic research collaboration will include an…
Continue Reading
BiondVax teams up with Max Planck Society on developing VHH antibodies against COVID-19